Revenue: The sum of all revenue fields included for a company's operating activities.
Immuneering Corporation (IMRX) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-15.05M |
|
-- |
|
-- |
|
$15.48M |
|
$-15.48M |
|
$0.44M |
|
$-15.05M |
|
$-15.05M |
|
$-15.05M |
|
$-15.05M |
|
$-15.05M |
|
$-15.05M |
|
$-15.48M |
|
$-15.31M |
|
35.53M |
|
35.53M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$38.21M |
|
$1.05M |
|
$12.48M |
|
$50.68M |
|
$5.11M |
|
-- |
|
$3.73M |
|
$8.84M |
|
$41.84M |
|
$34.81M |
|
$41.84M |
|
35.99M |
|
| Cash Flow Statement Financials | |
$-14.08M |
|
$-0.01M |
|
$13.81M |
|
$36.14M |
|
$35.87M |
|
$-0.28M |
|
$1.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.96% |
|
-43.22% |
|
-29.69% |
|
-35.96% |
|
$1.16 |
|
$-0.40 |
|
$-0.40 |
|